SUNSHINE BIOPHARMA INC (SBFM)

Company Profile

Sunshine Biopharma Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Fort Lauderdale, Florida and currently employs 44 full-time employees. The company went IPO on 2008-08-15. Sunshine Biopharma, Inc. is a Canada-based pharmaceutical company. The firm offers and researches life-saving medicines in a variety of therapeutic areas, including oncology and antivirals. The firm has over 32 additional generic prescription drugs. In addition, the Company is conducting a proprietary drug development program which consists of K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver cancer, and PLpro protease inhibitor, a small molecule for treatment of SARS Coronavirus infections. The firm operates through two segments: Prescription Generic Pharmaceuticals (Generic Pharmaceuticals) and Nonprescription Over-The-Counter Products (OTC Products). The company also operates two wholly owned subsidiaries: NoraPharma Inc., which has a portfolio of pharmaceutical products consisting of approximately 61 generic prescription drugs on the market in Canada, and Sunshine Biopharma Canada Inc., which develops and sells non-prescription over-the-counter (OTC) products.

Company Info

SUNSHINE BIOPHARMA INC

333 Las Olas Way, Cu4 Suite 433

FORT LAUDERDALE FLORIDA

P: 19545150810

Employees: 44

Website: https://www.sunshinebiopharma.com/